CN1022325C - 咪唑烷二酮衍生物的制备方法 - Google Patents
咪唑烷二酮衍生物的制备方法 Download PDFInfo
- Publication number
- CN1022325C CN1022325C CN88106484A CN88106484A CN1022325C CN 1022325 C CN1022325 C CN 1022325C CN 88106484 A CN88106484 A CN 88106484A CN 88106484 A CN88106484 A CN 88106484A CN 1022325 C CN1022325 C CN 1022325C
- Authority
- CN
- China
- Prior art keywords
- compound
- spiral shell
- hydrogen
- methyl
- mole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1987/002196 WO1989001775A1 (en) | 1987-09-04 | 1987-09-04 | Azolidinedione derivatives |
| USPCT/US87/02196 | 1987-09-04 | ||
| USPCT/US87/002196 | 1987-09-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1031702A CN1031702A (zh) | 1989-03-15 |
| CN1022325C true CN1022325C (zh) | 1993-10-06 |
Family
ID=22202540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN88106484A Expired - Fee Related CN1022325C (zh) | 1987-09-04 | 1988-09-03 | 咪唑烷二酮衍生物的制备方法 |
Country Status (21)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5068333A (en) * | 1990-03-07 | 1991-11-26 | Pfizer Inc. | 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration |
| DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
| KR101308227B1 (ko) * | 2005-04-21 | 2013-09-13 | 이시하라 산교 가부시끼가이샤 | 니코틴산 유도체 또는 그의 염의 제조 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| FR2455046A1 (fr) * | 1979-04-25 | 1980-11-21 | Science Union & Cie | Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| EP0065392B1 (en) * | 1981-05-13 | 1985-02-13 | Imperial Chemical Industries Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
-
1987
- 1987-09-04 WO PCT/US1987/002196 patent/WO1989001775A1/en active Application Filing
- 1987-09-04 MX MX1289688A patent/MX12896A/es unknown
- 1987-09-04 HU HU875809A patent/HU204832B/hu not_active IP Right Cessation
-
1988
- 1988-08-29 MY MYPI88000968A patent/MY103765A/en unknown
- 1988-08-29 IL IL87590A patent/IL87590A/xx unknown
- 1988-08-30 EP EP88307985A patent/EP0306251A3/en not_active Withdrawn
- 1988-09-01 JP JP63219621A patent/JPS6471882A/ja active Granted
- 1988-09-01 ZA ZA886507A patent/ZA886507B/xx unknown
- 1988-09-01 EG EG465/88A patent/EG18591A/xx active
- 1988-09-02 AU AU21841/88A patent/AU595467B2/en not_active Ceased
- 1988-09-02 CS CS591188A patent/CS273186B2/cs not_active IP Right Cessation
- 1988-09-02 DD DD88319458A patent/DD273381A5/de not_active IP Right Cessation
- 1988-09-02 PL PL1988274504A patent/PL156798B1/pl unknown
- 1988-09-02 PT PT88407A patent/PT88407B/pt not_active IP Right Cessation
- 1988-09-02 YU YU167788A patent/YU46863B/sh unknown
- 1988-09-02 PH PH37490A patent/PH24957A/en unknown
- 1988-09-02 DK DK488688A patent/DK488688A/da not_active Application Discontinuation
- 1988-09-03 CN CN88106484A patent/CN1022325C/zh not_active Expired - Fee Related
- 1988-09-03 KR KR1019880011369A patent/KR900008841B1/ko not_active IP Right Cessation
-
1990
- 1990-03-02 NO NO90901016A patent/NO901016L/no unknown
- 1990-03-02 FI FI901087A patent/FI901087A0/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| YU167788A (en) | 1990-06-30 |
| ZA886507B (en) | 1990-04-25 |
| CN1031702A (zh) | 1989-03-15 |
| IL87590A (en) | 1992-07-15 |
| DK488688D0 (da) | 1988-09-02 |
| JPS6471882A (en) | 1989-03-16 |
| FI901087A0 (fi) | 1990-03-02 |
| NO901016D0 (no) | 1990-03-02 |
| HU204832B (en) | 1992-02-28 |
| EG18591A (en) | 1993-06-30 |
| HUT56106A (en) | 1991-07-29 |
| NO901016L (no) | 1990-05-02 |
| CS591188A2 (en) | 1990-06-13 |
| WO1989001775A1 (en) | 1989-03-09 |
| KR890005112A (ko) | 1989-05-11 |
| JPH0583554B2 (US06312121-20011106-C00033.png) | 1993-11-26 |
| AU595467B2 (en) | 1990-03-29 |
| PL274504A1 (en) | 1989-05-02 |
| DK488688A (da) | 1989-04-07 |
| CS273186B2 (en) | 1991-03-12 |
| YU46863B (sh) | 1994-06-24 |
| AU2184188A (en) | 1989-03-09 |
| PT88407B (pt) | 1992-10-30 |
| EP0306251A2 (en) | 1989-03-08 |
| KR900008841B1 (ko) | 1990-11-30 |
| EP0306251A3 (en) | 1990-08-01 |
| PT88407A (pt) | 1989-07-31 |
| PL156798B1 (pl) | 1992-04-30 |
| MX12896A (es) | 1993-06-01 |
| IL87590A0 (en) | 1989-01-31 |
| PH24957A (en) | 1990-12-26 |
| MY103765A (en) | 1993-09-30 |
| DD273381A5 (de) | 1989-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1155600C (zh) | 2,3-二芳基吡唑并[1,5-b]哒嗪衍生物,其制备方法和用作环氧酶2抑制剂 | |
| CN1080260C (zh) | 取代的吲哚衍生物以及它们作为iv型磷酸二酯酶(pde)和肿瘤坏死因子(tnf)抑制剂的用途 | |
| CN1052005C (zh) | 咪唑并吡啶、其制法和药用 | |
| CN87101691A (zh) | 碳环嘌呤核苷，它们的制备及应用 | |
| CN1216544A (zh) | 新的N－7－杂环基－吡咯并[2,3－d]嘧啶及其应用 | |
| CN1382142A (zh) | 作为p38蛋白激酶的抑制剂的烷基氨基－取代的双环氮杂环类化合物 | |
| CN1219131A (zh) | 作为tnf抑制剂和pdc－iv抑制剂的喹啉甲酰胺类化合物 | |
| CN1015057B (zh) | 哌嗪基-杂环化合物的制备方法 | |
| CN1090634C (zh) | 喜树碱的前药形式和类似物,及其药物用途 | |
| CN1430603A (zh) | 新型双环化合物 | |
| CN1092657C (zh) | 一釜法合成2－噁唑烷酮衍生物 | |
| CN1169149A (zh) | 止痛组合物 | |
| CN1069643C (zh) | 抑制巨细胞病毒的二氮杂萘及其类似物 | |
| CN1109471A (zh) | 咪唑-4-基哌啶衍生物及其制备方法和在治疗中的应用 | |
| CN1062138A (zh) | Hiv反转录酶抑制剂的增效 | |
| CN1048014C (zh) | 取代的吡咯类化合物及其制法、药物组合物和用途 | |
| CN1201463A (zh) | 新型核苷衍生物及其制备方法 | |
| CN1015334B (zh) | 新苯并唑衍生物的制备方法 | |
| CN1033451C (zh) | α-取代的苯甲胺衍生物 | |
| CN1056102A (zh) | 新的哒嗪及其制备方法 | |
| CN1022325C (zh) | 咪唑烷二酮衍生物的制备方法 | |
| CN1082370C (zh) | 含有4－氧代－丁酸的药物组合物 | |
| CN1009826B (zh) | 制备喹啉基化合物的方法 | |
| CN1026489C (zh) | 抗鼻病毒的(硫代)吗啉基和哌嗪基烷基酚醚的制备方法 | |
| CN1118599A (zh) | 用作腺苷a1受体拮抗剂的黄嘌呤衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |